Cell line · CVCL_6027
Papers32
1 to 20 of 32
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Hexokinase2-engineered T cells display increased anti-tumor function. | Front Immunol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Targeting TGFβ with chimeric switch receptor and secreted trap to improve T cells anti-tumor activity. | Front Immunol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Genetically engineering glycolysis in T cells increases their antitumor function. | J Immunother Cancer | 2024 | Its Methods give the RRID and name the line | PubMed | |
| The CD73 immune checkpoint promotes tumor cell metabolic fitness. | Elife | 2023 | Its Methods give the RRID and name the line | PubMed | |
| An adverse tumor-protective effect of IDO1 inhibition. | Cell Rep Med | 2023 | Its Methods give the RRID and name the line | PubMed | |
| A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function. | J Immunother Cancer | 2019 | Its Methods give the RRID and name the line | PubMed | |
| TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression. | Genome Med | 2015 | Cellosaurus cites it | PubMed | |
| A resource for cell line authentication, annotation and quality control. | Nature | 2015 | Cellosaurus cites it | PubMed | |
| A comprehensive transcriptional portrait of human cancer cell lines. | Nat Biotechnol | 2015 | Cellosaurus cites it | PubMed | |
| Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence. | Cancer Res | 2014 | Cellosaurus cites it | PubMed | |
| Investigating the role of melanin in UVA/UVB- and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells. | Free Radic Biol Med | 2012 | Cellosaurus cites it | PubMed | |
| Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. | Oncogene | 2012 | Cellosaurus cites it | PubMed | |
| Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma. | Cancer Res | 2007 | Cellosaurus cites it | PubMed | |
| Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. | Oncogene | 2004 | Cellosaurus cites it | PubMed | |
| Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. | J Invest Dermatol | 2004 | Cellosaurus cites it | PubMed | |
| Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. | Cancer Res | 2000 | Cellosaurus cites it | PubMed | |
| Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. | Oncogene | 1998 | Cellosaurus cites it | PubMed | |
| Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy. | J Immunol | 1998 | Cellosaurus cites it | PubMed | |
| Characterization of gene regulatory elements for selective gene expression in human melanoma cells. | Biochem Biophys Res Commun | 1995 | Cellosaurus cites it | PubMed | |
| Production and characterization of antibodies against human tyrosinase. | J Invest Dermatol | 1994 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_6027/papers